BKYI BIO KEY INTERNATIONAL INC
Services-Prepackaged Software · Nasdaq · SEC CIK 1019034 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.0%
TTM net income YoY-40.1%
TTM EPS YoY—
Revenue 3-yr CAGR-4.8%
Net income 3-yr CAGR—
Margins
Gross margin84.4%
Operating margin-86.2%
Net margin-89.8%
FCF margin-67.5%
EBITDA margin-85.3%
Returns
ROE-94.7%
ROA-62.8%
ROIC (approx.)-108.5%
Asset turnover0.70x
Leverage & solvency
Liabilities / assets26.0%
Debt / equity0.00x
Current ratio2.47x
Interest coverage-129.12x
Cash quality & payout
Operating cash flow / net income0.75x
Accruals ratio-15.7%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.48M | $1.92M | $2.15M | $1.08M | $1.55M | $1.70M | $1.61M | $1.46M |
| Cost of revenue | $143,373 | $245,951 | $376,300 | $271,371 | $357,988 | $464,180 | $279,498 | $262,360 |
| Gross profit | $1.34M | $1.67M | $1.77M | $812,412 | $1.19M | $1.23M | $1.33M | $1.20M |
| R&D expense | $635,038 | $640,418 | $616,880 | $694,471 | $683,620 | $636,027 | $595,775 | $660,151 |
| SG&A expense | $1.52M | $1.56M | $1.31M | $1.83M | $1.40M | $1.68M | $1.37M | $1.81M |
| Operating income | -$820,213 | -$529,405 | -$157,713 | -$4.21M | -$892,190 | -$1.08M | -$640,638 | -$1.27M |
| Interest expense | $4,048 | $27,000 | $27,166 | -$13,929 | $13,174 | $25,638 | $35,910 | $66,932 |
| Pretax income | -$886,083 | -$576,852 | -$205,037 | -$4.27M | -$964,849 | -$1.17M | -$736,545 | -$1.41M |
| Income tax | $0 | $0 | $0 | $16,500 | $0 | $0 | $0 | -$22,998 |
| Net income | -$886,083 | -$576,852 | -$205,037 | -$4.29M | -$964,849 | -$1.17M | -$736,545 | -$1.38M |
| EBITDA | -$809,640 | -$511,174 | -$142,997 | -$4.19M | -$870,924 | -$1.06M | -$618,856 | -$1.24M |
| EPS (basic) | -4.01 | -0.56 | -0.20 | — | -1.44 | -2.01 | -1.57 | — |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $2.22M | $1.38M | $2.25M | $2.69M | $2.04M | $2.28M | $3.13M | $437,604 |
| Receivables | $2.35M | $1.73M | $1.57M | $1.22M | $959,503 | $983,534 | $803,277 | $718,229 |
| Inventory | $367,063 | $375,740 | $338,397 | $370,879 | $394,176 | $318,538 | $357,842 | $378,307 |
| Current assets | $5.28M | $3.81M | $4.49M | $4.54M | $3.75M | $4.04M | $4.59M | $1.89M |
| PP&E, net | $32,051 | $34,804 | $53,035 | $67,751 | $82,557 | $102,499 | $122,986 | $140,198 |
| Intangibles | $662,572 | $718,430 | $774,318 | $830,357 | $886,563 | $942,892 | $1.02M | $1.10M |
| Total assets | $8.84M | $7.48M | $8.16M | $8.30M | $10.11M | $10.52M | $11.18M | $8.62M |
| Current liabilities | $2.14M | $3.01M | $3.19M | $3.10M | $2.96M | $3.53M | $3.47M | $4.55M |
| Long-term debt | — | — | — | — | — | $0 | $11,666 | $44,762 |
| Total debt | — | — | — | — | — | $0 | $11,666 | $44,762 |
| Total liabilities | $2.30M | $3.15M | $3.26M | $3.20M | $4.07M | $3.66M | $3.66M | $4.84M |
| Shareholders' equity | $6.54M | $4.33M | $4.89M | $5.11M | $6.05M | $6.85M | $7.53M | $3.77M |
| Net debt | — | — | — | — | — | -$2.28M | -$3.12M | -$392,842 |
| Shares outstanding | 2.04M | 1.09M | 1.09M | 1.09M | 7.31M | 6.85M | 5.81M | 371,696 |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.43M | -$845,749 | -$358,001 | -$1.83M | -$1.12M | -$880,012 | -$835,312 | -$514,564 |
| Capital expenditure | $7,819 | $0 | $0 | $4,639 | $1,325 | $1,478 | $4,570 | -$10,000 |
| Free cash flow | -$1.44M | -$845,749 | -$358,001 | -$1.84M | -$1.12M | -$881,490 | -$839,882 | -$504,564 |
| Investing cash flow | -$7,819 | $0 | $0 | -$4,639 | -$1,325 | -$1,478 | -$4,570 | $10,000 |
| Financing cash flow | $2.34M | $7,660 | -$38,179 | $2.46M | $962,508 | -$35,722 | $3.53M | -$833,560 |
| Depreciation & amortization | $10,573 | $18,231 | $14,716 | $19,444 | $21,266 | $21,966 | $21,782 | $23,911 |
| Stock-based compensation | $47,652 | $42,652 | $40,744 | $60,590 | $31,660 | $21,837 | $52,488 | $71,633 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.